In recent years, this symposium has been gathering every year around 170 participants, half from universities, half from industry, both from Belgium and surrounding countries. It has been focussing on topics such as "New Vistas in GPCR Research: the Dawn of an Exciting Drug Discovery Era?" (2014); 鈥淐onstrained Peptides and Macrocycles 鈥� New Opportunities for Drug Discovery鈥� (2013); 鈥淔rom Rapid Dissociation to Irreversible Inhibition 鈥� Optimisation of Drug-Target Residence Time鈥� (2012); 鈥淓merging Targets and Treatments: Opportunities and Challenges for Drug Design鈥� (2011); 鈥淒oes size matter? Beyond small molecule therapeutics: challenges and success stories鈥� (2009); 鈥淪mall molecules, Antibodies and Natural Products: Multiple Faces of Medicinal Chemistry鈥� (2008); or 鈥淣ew Drugs and Drug Candidates: Recent Achievements in Medicinal Chemistry (2007)鈥�.
MedChem 2016, with six invited lectures and three oral communications, will be held on Friday November 18, 2016, at the Espace Edison 鈥� Axis Parc in Mont-Saint-Guibert. The title and focus of the symposium will be 鈥淧ET & Imaging : From Chemistry Lab to Clinical Applications鈥�.
The objective of the one-day symposium is to delve into the latest developments around Positron Emission Tomography (PET) and Imaging as invaluable non-invasive translational evaluation and diagnostic tools in drug discovery. Medicinal chemistry now plays a critical role in the design, the synthesis and the characterization of suitable ligands with very specific properties. A sightseeing tour around state-of-the-art synthetic methodologies, tracers design and optimization principles, recent applications and perspectives in various therapeutic areas as well as selected case-studies will be presented.
MedChem 2016, with six invited lectures and three oral communications, will be held on Friday November 18, 2016, at the Espace Edison 鈥� Axis Parc in Mont-Saint-Guibert. The title and focus of the symposium will be 鈥淧ET & Imaging : From Chemistry Lab to Clinical Applications鈥�.
The objective of the one-day symposium is to delve into the latest developments around Positron Emission Tomography (PET) and Imaging as invaluable non-invasive translational evaluation and diagnostic tools in drug discovery. Medicinal chemistry now plays a critical role in the design, the synthesis and the characterization of suitable ligands with very specific properties. A sightseeing tour around state-of-the-art synthetic methodologies, tracers design and optimization principles, recent applications and perspectives in various therapeutic areas as well as selected case-studies will be presented.
